Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China · Delayed Price · Currency is CNY 15.53
-0.17 (-1.08%)
Feb 4, 2026, 2:45 PM CST
SHE:002923 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -51.99 | 39.88 | 66.9 | 155.48 | 139.77 | 135.86 |
Depreciation & Amortization | 136.54 | 136.54 | 112.87 | 72.23 | 63.7 | 49.98 |
Other Amortization | 6.1 | 6.1 | 4.66 | 5.85 | 8.96 | 11.28 |
Loss (Gain) From Sale of Assets | - | - | -0.15 | -0.05 | - | - |
Asset Writedown & Restructuring Costs | 0.43 | 0.43 | 0.15 | 0.33 | 0.23 | 2.29 |
Loss (Gain) From Sale of Investments | -0.09 | -0.09 | 0.36 | -0.1 | -0.41 | -3.65 |
Provision & Write-off of Bad Debts | 0.14 | 0.14 | 0.16 | 2.56 | 0.49 | -0.68 |
Other Operating Activities | 1.33 | 29.82 | 58.52 | 36.84 | 6.17 | 10.77 |
Change in Accounts Receivable | 27.13 | 27.13 | -11.95 | -53.67 | -239.24 | 33.65 |
Change in Inventory | -9.53 | -9.53 | 20.92 | -132.53 | -37.38 | -68.96 |
Change in Accounts Payable | -18.97 | -18.97 | -81.62 | 49.69 | 267.29 | 63.16 |
Change in Other Net Operating Assets | - | - | - | - | -6.7 | 18.94 |
Operating Cash Flow | 90.83 | 211.19 | 172.68 | 135.01 | 205.91 | 250.35 |
Operating Cash Flow Growth | -60.92% | 22.30% | 27.90% | -34.43% | -17.75% | 65.46% |
Capital Expenditures | -20.47 | -81.25 | -174.53 | -251.75 | -376.48 | -256.74 |
Sale of Property, Plant & Equipment | - | - | - | 0.07 | - | - |
Investment in Securities | -0 | -0 | - | 0.13 | 44.43 | 93.64 |
Other Investing Activities | 0.17 | 0.08 | - | - | - | - |
Investing Cash Flow | -20.3 | -81.17 | -174.53 | -251.56 | -332.06 | -163.11 |
Long-Term Debt Issued | - | 53.89 | 193.44 | 234.43 | 286 | 58.03 |
Long-Term Debt Repaid | - | -126.94 | -90.36 | -57.69 | -76.33 | -17.96 |
Net Debt Issued (Repaid) | 38.77 | -73.05 | 103.07 | 176.74 | 209.67 | 40.07 |
Issuance of Common Stock | - | - | - | - | - | 4.66 |
Repurchase of Common Stock | - | - | - | -13.86 | -1.66 | -0.22 |
Common Dividends Paid | -65.57 | -84.7 | -102.38 | -89.68 | -82.65 | -76.34 |
Other Financing Activities | -56.67 | - | -5.17 | - | 29.65 | -26.64 |
Financing Cash Flow | -83.48 | -157.75 | -4.48 | 73.2 | 155.01 | -58.48 |
Foreign Exchange Rate Adjustments | 1.58 | 2.43 | 0.4 | 1.37 | -0.59 | -1.55 |
Net Cash Flow | -11.37 | -25.3 | -5.93 | -41.98 | 28.27 | 27.21 |
Free Cash Flow | 70.36 | 129.94 | -1.85 | -116.75 | -170.58 | -6.4 |
Free Cash Flow Growth | -38.48% | - | - | - | - | - |
Free Cash Flow Margin | 5.91% | 10.99% | -0.14% | -8.51% | -14.34% | -0.51% |
Free Cash Flow Per Share | 0.21 | 0.39 | -0.01 | -0.34 | -0.51 | -0.02 |
Cash Income Tax Paid | 74.86 | 77.33 | 40.08 | 81.25 | 76.66 | 83.79 |
Levered Free Cash Flow | 57.1 | 125.88 | -135.04 | -129.24 | -207.03 | -96.55 |
Unlevered Free Cash Flow | 65.7 | 135.75 | -124.97 | -124.89 | -205.92 | -95.45 |
Change in Working Capital | -1.63 | -1.63 | -70.78 | -138.12 | -12.99 | 44.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.